Bangkok, Thailand
Bangkok, Thailand

Time filter

Source Type

— Global Rabies Treatment Market Information, by Type (Furious Rabies, Paralytic Rabies and others), by Treatment (Rabies Immunoglobulin Vaccine, Brain Tissue Vaccines, Tissue Culture Vaccines and others), by End Users (Hospital, Clinics, Epidemic Prevention Centers and others) - Forecast to 2022 Rabies is a life-threatening condition that causes tens of thousands of deaths worldwide every year. It is a disease, where humans may get from being bitten by an animal infected with the rabies virus. It gets transmitted through saliva touching an open wound or touching mucous membranes. This virus infects the brain and ultimately leads to death. Study Objectives of Rabies Treatment Market: • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the rabies treatment market • To provide insights about factors affecting the market growth • To analyze the rabies treatment market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segments by type, by treatment, by end users and its sub-segments. • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global rabies treatment market. Intended Audience: • Companies into Rabies treatment • Research and Development (R&D) Companies • Independent Research Laboratories • Market Research and Consulting Service Providers • Medical Research Laboratories Global rabies treatment market has been segmented on the basis of type which comprise of Furious Rabies, Paralytic Rabies and others. On the basis of treatment; market is segmented into; Rabies immunoglobulin vaccine, Brain tissue vaccines, Tissue culture vaccines and others. On the basis of end users; market is segmented as; hospital, clinics, epidemic prevention centers and others. Key Players for Rabies Treatment Market: • Sanofi (France) • Merck Animal Health • CSC PHARMACEUTICALS INTERNATIONAL • Pfizer (US) • VBI Vaccines Inc. (US) • Taj Pharmaceuticals Limited. (India) • Bio Med Pvt. Ltd Request for Table of Content at https://www.marketresearchfuture.com/request-toc/1629 . The report for Global Rabies Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions For more information, please visit https://www.marketresearchfuture.com/reports/rabies-treatment-market


News Article | May 12, 2017
Site: marketersmedia.com

Malignant Lymphoma Market Information, by types (Hodgkin lymphoma and Non Hodgkin lymphoma), by treatment (chemotherapy, radiation therapy, immunotherapy, stem cell therapy and others) - Forecast to 2022 Pune, India - May 11, 2017 /MarketersMedia/ — Malignant Lymphoma Market Information, by types (Hodgkin lymphoma and Non Hodgkin lymphoma), by treatment (chemotherapy, radiation therapy, immunotherapy, stem cell therapy and others) - Forecast to 2022 The lymphatic system runs throughout our bodies. Cancers that develop anywhere in body’s lymphatic system are called as lymphoma and if they have the ability to spread in the body, they are called malignant lymphoma. The most common symptom of the lymphoma is swollen glands. Men are more prone to lymphoma compared to women for the reason unknown. Globally the market for malignant lymphoma is increasing rapidly. Get a sample copy @ https://www.marketresearchfuture.com/sample_request/1861 . Study objectives of Malignant Lymphoma Market: • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the malignant lymphoma market. • To provide insights about factors affecting the market growth • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segments by type, by treatment and its sub-segments. • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global malignant lymphoma market. Complete Report Available at https://www.marketresearchfuture.com/reports/malignant-lymphoma-market . Intended Audience • Malignant lymphoma drug manufacturers & Suppliers • Contract Research Organizations (CROs) • Research and Development (R&D) Companies • Government Research Laboratories • Independent Research Laboratories • Government and Independent Regulatory Authorities • Market Research and Consulting Service Providers • Academic Institutes and Universities Malignant lymphoma market has been segmented on the basis of types which comprises of Hodgkin lymphoma and non-Hodgkin lymphoma. On the basis of treatments, market is segmented into chemotherapy, radiation therapy, immunotherapy, stem cell therapy and others. Globally North America is the largest market for malignant lymphoma. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for malignant lymphoma. Request for Discount at https://www.marketresearchfuture.com/check-discount/1861 Some of the key players in this market are: • Abbott Laboratories • ABIOGEN PHARMA S.p.A. • Actelion Pharmaceuticals • Aeterna Zentaris, Inc. • Allos Therapeutics • Astellas Pharma • Bristol-Myers Squibb Company • Celgene Corporation • Eli Lilly and Company • Genmab • Inovio Pharmaceuticals • Johnson & Johnson • Merck & Co. Inc. • Novartis • Onyx Pharmaceuticals • Roche • Seattle Genetics North America • US • Canada • Europe Western Europe • Germany • France • Italy • Spain • UK • Rest of Western Europe • Eastern Europe Asia • China • India • Japan • South Korea • Rest of AsiaPacific Middle East & Africa The report for Malignant Lymphoma Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions List of Tables TABLE 1 GLOBAL MALIGNANT LYMPHOMA MARKET, BY TYPES, 2013-2022 (USD MILLION) TABLE 2 GLOBAL MALIGNANT LYMPHOMA MARKET, BY TREATMENT, 2013-2022 (USD MILLION) TABLE 3 GLOBAL MALIGNANT LYMPHOMA MARKET, BY REGION, 2013-2022 (USD MILLION) List of Figures FIGURE 1 RESEARCH PROCESS FIGURE 2 PORTERS FIVE FORCES MODEL FIGURE 3 GLOBAL MALIGNANT LYMPHOMA MARKET, BY TYPES FIGURE 4 GLOBAL MALIGNANT LYMPHOMA MARKET, BY TREATMENT FIGURE 5 GLOBAL MALIGNANT LYMPHOMA MARKET, BY REGION FIGURE 6 GLOBAL MALIGNANT LYMPHOMA MARKET: COMPANY SHARE ANALYSIS, 2015 (%) Contact Info:Name: Akash AnandEmail: Akash.Anand@Marketresearchfuture.ComOrganization: Market Research FutureAddress: Market Research Future Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, IndiaPhone: +1 646 845 9312Source URL: http://marketersmedia.com/malignant-lymphoma-market-research-report-global-forecast-to-2022/198744For more information, please visit https://www.marketresearchfuture.com/reports/malignant-lymphoma-marketSource: MarketersMediaRelease ID: 198744


Globally the market for Retinal Detachment treatment is increasing rapidly. The major factor that derives the growth of Retinal Detachment treatment is the increasing aging population. Furthermore increased risk and complication in diabetes called diabetic retinopathy and high life expectancy are developing the market for retinal detachment treatment. • Retinal Surgery Treatment Centers • Contract Research Organizations (CROs) • Research and Development (R&D) Companies • Government Research Laboratories • Independent Research Laboratories • Government and Independent Regulatory Authorities • Market Research and Consulting Service Providers • Medical Research Laboratories • Academic Medical Institutes and Universities The report for Global Retinal Detachment treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Taste the market data and market information presented through more than 50 market data tables and figures spread in 85 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Retinal Detachment treatment Market Research Report- Forecast To 2022" Study Objectives of Retinal Detachment treatment Market: • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the retinal detachment treatment market • To provide insights about factors affecting the market growth • To analyze the retinal detachment treatment market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segments by retinal detachment, by treatment and its sub-segments. • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global retinal detachment treatment market. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions Browse Related Reports: Global Thymus Cancer Information, by types (type A, type AB, type B1, type B2, type B3 and thymic carcinoma), by treatment (surgery, radiotherapy, chemotherapy and others) By care centers (Hospitals, Clinics, Diagnostic centers, Research laboratories and others) - Forecast to 2024 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com/reports/retinal-detachment-treatment-market


— Market Highlights The North America microarray market has been evaluated as slowly growing market and expected to continue in the similar way in the near future. A microarray is a multiplex lab-on-a-chip. It is a 2D array on a solid substrate, usually a glass slide or silicon thin-film cell, that assays large amounts of biological material using high-throughput screening miniaturized, multiplexed and parallel processing and detection methods. Globally the Microarray Market is dominated by DNA microarrays. The protein microarray is currently the fastest growing market. The use of peptide and carbohydrate microarrays is expanding. Tissue and cell microarrays are in their infancy stage and are developing slowly because of many complications in the process development. Microarray is one of the methods which was used for the diagnostic purpose in cancer research. But commonly used types like DNA microarray, antibody array have not been proven to be effective methods in case of the disease like cancer. So in order to deal with the limitations of other types, tissue microarray was developed. Tissue microarray is an effective diagnostic tool for cancer diagnosis. The more and more research is going on to make the tissue microarray more accurate and efficient. As the prevalence of cancer is spreading, the growth in the tissue microarray method is expected in the future. North America Microarray Market Players: • ABCAM • Asterand Bioscience • IHC World LLC • Novus Biologicals LLC (Acquired By BIO-TECHNE) • Origene Technologies Inc • Pantomics, Inc • Protein Biotechnologies Inc • US Biomax, Inc. • US Bioupton Int • Vitrovivo Biotech, LLC On the other hand, as the technique is in its infancy stage, lots of mistakes and errors occur. The readings are not accurate many times. As the results are not reliable, it creates a hindrance in the growth of the tissue microarray method. Besides this, tissue microarrays are not recommended for certain types of studies. In certain tumors such as glioblastoma, there is such marked heterogeneity within tumors that this feature may not be adequately captured in tissue microarray studies. In addition, microarrays are also not very useful to study rare or focal events, such as number of immune cells in tumors. These are some of the factors that cause hindrance to the growth of the Tissue microarray market. Regional Analysis: North America tissue microarray market is segmented into two countries: United States, and Canada. U.S. is the largest market for tissue microarray. The U.S market for tissue microarray is expected to reach at USD 364.2 million by the end of the forecasted period. Canada is the second-largest market for tissue microarray which is expected to grow at a CAGR of 4.4%. Key Finding - The North America microarray market is expected to reach $1,635.4 billion by 2027. - Paraffin tissue sections (FFPE) hold the largest share of 54.6% of the North America Tissue Microarray market. - S. holds the largest market share of North America Tissue Microarray market and is anticipated to reach $364.2 million by the end of 2027. - Immunohistochemistry segment holds the largest market share of 47.5% in 2015. Segmentation: North America Microarray market has been segmented on the basis of types which comprises of protein microarray, tissue microarray, and cellular microarray. On the basis of product, North America Tissue microarray market is segmented into paraffin tissue sections (FFPE), frozen tissue sections, and others. On the basis of applications, tissue microarray market is segmented into immunohistochemistry, in-situ hybridization, and others. Intended Audience - Contract Research Organizations (CROs) - Research and Development (R&D) Companies - Government Research Laboratories - Independent Research Laboratories - Government and Independent Regulatory Authorities - Academic Institutes and Universities Related Report The global market for clinical data analytics is expected to reach USD 11,853.6 million by the end of the forecasted period and is expected to grow at a CAGR of 30.90%. https://www.marketresearchfuture.com/reports/clinical-data-analytics-market-2520 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. For more information, please visit https://www.marketresearchfuture.com/reports/north-america-microarray-market-2641


News Article | May 17, 2017
Site: www.eurekalert.org

Vaccines are an essential tool for preventing and treating serious infectious diseases such as polio, chicken pox and measles. But so far it has not been possible to develop vaccines capable of contributing to the treatment and prevention of chronic infectious diseases such as HIV and hepatitis C. This new research paves the way for vaccines that, as opposed to conventional methods, boosting the parts of the immune system attacking the viral genes, which are the least active during the infection. This prolongs the resistance of the immune system to the virus. Traditional vaccines typically cause a strong stimulation of the parts of the immune system, that are most responsive to the specific virus. But the reaction to the vaccine and the infection is often so intense that the immune system 'loses momentum' and consequently is not able to completely eliminate the virus. Researchers have therefore designed a vaccine which boosts the cells of the immune system responsible for the less exposed parts of the virus. As a result, the cells are able to distribute the 'work load' and retain the defense against the virus attack for a longer period of time. This gives the immune system time to build a more efficient defense, which may then defeat the remaining of the virus. "We're presenting an entirely new vaccine solution. Our vaccine supports the work of the immune system in developing an effective combating mechanism against the virus, rather than immediately combating the toughest parts of the virus. In combination with other vaccines, this approach can prove to have a highly efficient effect," says Research Team Leader and Associate Professor Peter Holst of the Department of Immunology and Microbiology. In 2008, the research team decided to develop a new vaccine strategy, which generates so-called strong immune responses against weak immunostimulatory parts of viruses. Research initially focused on experiments on mice and later on monkeys. Now, the results of the research team show, that this technology can control the SIV virus infection (simian immunodefiency virus) in monkeys. SIV is a chronic infectious disease and a highly realistic representation of HIV. The results are an important step toward developing a vaccine against HIV and other chronic infections. "The next phase of our work is to build virus control in all infected animals and later in humans. We're convinced that it's possible to identify further improvements in our experiments and thus achieve a well-functioning vaccine, initially against HIV, but also against other chronic infections," says Peter Holst. The study 'Mucosal vaccination with heterologous viral vectored vaccine targeting subdominant SIV accessory antigens strongly inhibits early viral replication' was published in the scientific journal EbioMedicine. The study is supported by the Danish AIDS Foundation and the Danish Council for Independent Research. The concept is a further development of previous studies of chronic infections in mice, originally carried out in collaboration with Professors Jan Pravsgaard and Allan Randrup from the University of Copenhagen.


— Global Market for Bladder Cancer is growing rapidly and expected to continue its growth by the end of 2022 Global Bladder Cancer Market has been evaluated as rapidly growing market and expected that the market will reach high growth figures. There has been a tremendous growth in the number of people getting diagnosed with bladder cancer. Men are seen to be more prone to bladder cancer than women. According to the National Institutes of Health, approximately 45,000 men and 17,000 women per year are diagnosed with the disease only in U.S. The exact reason causing bladder cancer is unknown. However, there are few risk factors which can cause bladder cancer such as successive exposure to radiation, previous cancer treatments, excessive smoking, and chronic bladder infection among others. The most common treatment for the bladder cancer is chemotherapy. • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the bladder cancer market • To provide insights about factors affecting the market growth • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segments by type, by treatment, by end user and its sub-segments. • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global bladder cancer market. Access the market data and market information presented through more than 25 market data tables and 25 figures spread over 85 numbers of pages of the project report “Bladder Cancer Market – Global Forecast to 2022” • Bladder cancer treatment devices manufacturers & Suppliers • Bladder cancer treatment drug manufacturers & Suppliers • Contract Research Organizations (CROs) • Research and Development (R&D) Companies • Government Research Laboratories • Independent Research Laboratories • Government and Independent Regulatory Authorities • Market Research and Consulting Service Providers • Academic Institutes and Universities FIGURE 1 Research Process FIGURE 2 Porters Five Forces Model FIGURE 3 Global Bladder Cancer Market, By Types FIGURE 4 Global Bladder Cancer Market, By Treatment At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com


News Article | April 24, 2017
Site: marketersmedia.com

Global Allergic Rhinitis Information, by treatment (steroids, antihistamines, decongestants, eye drops, nasal sprays, allergy shots, SLIT), by distribution channels (hospitals, clinics, pharmacies and others) - Forecast to 2022Pune, India - April 24, 2017 /MarketersMedia/ — Market Highlights: Allergic rhinitis is a chronic inflammatory disease affecting the nasal cavity which occurs when a person breathe in something he is allergic to. This disease affects almost every age group. The symptoms include itchy nose/mouth/eyes, problems with smell, runny nose, sneezing, watery eyes. Allergic rhinitis is typically triggered by environmental allergens such as pollen, pet hair, dust, or mold. Inherited genetics and environmental exposures mainly contribute to the development of allergies. Rising incidences of allergic rhinitis, over exposure to the animals or pets, rise in the pollution are some of the key factor responsible for the growth of the global allergic rhinitis market. The market for allergic rhinitis is growing rapidly. Major Key Players • Alcon Inc. • Array BioPharma Inc • AstraZeneca • Dainippon Sumitomo Pharma Co. Ltd. • Genentech Inc. • GlaxoSmithKline PLC • Hisamitsu Pharmaceutical Co. Inc • Meda Pharmaceuticals • Merck • Novartis AG • Nektar Therapeutics • Sanofi • Stallergenes S.A. Request a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1547 Intended Audience • Anti-allergy drugs manufacturers • Anti-allergy drugs suppliers • Research and Development (R&D) Companies • Government Research Laboratories • Independent Research Laboratories • Government and Independent Regulatory Authorities • Market Research and Consulting Service Providers • Medical Research Laboratories • Academic Medical Institutes and Universities The report for Global Allergic Rhinitis Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. Taste the market data and market information presented through more than 50 market data tables and figures spread in 85 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Allergic Rhinitis Market Research Report- Forecast To 2022” Browse Full Report Details @ https://www.marketresearchfuture.com/reports/allergic-rhinitis-market Study Objectives Allergic Rhinitis Market: • To provide detailed analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the allergic rhinitis market • To provide insights about factors affecting the market growth • To analyze the allergic rhinitis market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa. • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segments by treatment, distribution channels and its sub-segments. • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global allergic rhinitis market. Make an Enquiry @ https://www.marketresearchfuture.com/enquiry/1547 Market Segments: Segmentation by Treatment • Steroids • Antihistamines • Decongestants • Eye Drops • Nasal Sprays • Allergy Shots • SLIT Segmentation by distribution channels • Hospitals • Clinics • Pharmacies The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions. Browse Related Reports:- Global Thymus Cancer Information, by types (type A, type AB, type B1, type B2, type B3 and thymic carcinoma), by treatment (surgery, radiotherapy, chemotherapy and others) By care centers (Hospitals, Clinics, Diagnostic centers, Research laboratories and others) - Forecast to 2024 https://www.marketresearchfuture.com/reports/thymus-cancer-market About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Contact Info:Name: Akash AnandEmail: akash.anand@marketresearchfuture.comOrganization: Market Research FutureAddress: Hadapsar Pune, India - 411028Phone: +1 646 845 9312Source URL: http://marketersmedia.com/allergic-rhinitis-market-positive-long-term-growth-outlook-2016-2022/189524For more information, please visit https://www.marketresearchfuture.com/reports/allergic-rhinitis-marketSource: MarketersMediaRelease ID: 189524


— Market Highlights: North America Clinical laboratory testing has emerged as the most growing segment of healthcare over the past few years. Clinical laboratory testing includes all routine check-ups and other pathology tests for the diagnosis of various diseases ranging from CBC and other routine blood test, anatomical pathological testing, molecular, immunological, drug testing and other tests for disease diagnosis and treatment. Test the market data and market information presented through more than 50 market data tables and figures spread over 51 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “North America clinical laboratory Test Market Research Report – Forecast to 2022”. Key Findings: • The North America clinical laboratory test market, is expected to reach USD140.8 billion by 2022. • U.S. holds the largest share of 88 % of the North America clinical laboratory test market. Segmentation: The North America Clinical Laboratory Test Market is majorly segmented on the basis of type of laboratory, type of test, and by country. Based on the type of laboratory, the market is segmented into hospital based laboratory, central/ independent laboratory, physician office laboratory, and others. Based on type of test these are classified into CBC and other routine test, anatomic pathology, molecular test, immunology test, drug test and others. Further on the basis of country the market is classified into U.S., Canada, and Rest of North America. Intended Audience: • North America clinical laboratory commodities manufacturers & Suppliers • Contract Research Organizations (CROs) • Research and Development (R&D) Companies • Government Research Laboratories • Independent Research Laboratories • Government and Independent Regulatory Authorities • Market Research and Consulting Service Providers • Academic Institutes and Universities About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. For more information, please visit https://www.marketresearchfuture.com/reports/america-clinical-laboratory-test-market-2249


News Article | April 24, 2017
Site: marketersmedia.com

Middle-East and Africa Colorectal Cancer Market Analysis by Type (Adenocarcinomas), Diagnosis (Faecal Occult Blood Test) and Treatment Type - Forecast to 2022Pune, India - April 24, 2017 /MarketersMedia/ — Market Overview: Middle-East and Africa Colorectal Cancer Market has been evaluated as steadily growing market and it is expected that the market will continue to grow at same pace in the near future. Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers can also know as colon cancer or rectal cancer, depending on where they start. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, Diarrhea, Pains in the abdomen, Vomiting, and feeling tired all the time. Globally, around 1.4 million people diagnosed in 2014, in Middle-East and Africa approximately 5000 are suffering from Colorectal Cancer throughout Middle-East and Africa. About 80% of orphan disorders are genetic origin. Rising consumer awareness and continuous development of treatment for Colorectal Cancer are driving the growth for the Middle-East and Africa colorectal cancer market. Major drugs manufacturers are investing amount of money for R & D to find cure for colorectal cancer. Increasing funding and overall increased expenditure for healthcare, developing infrastructure, and expanded insurance coverage are leading the growth for Middle-East and Africa Colorectal Cancer. Middle-East and Africa Colorectal Cancer Market was estimated around US$ 0.8 billion in 2015 and is expected to reach US$ 0.90 billion by 2022 at a CAGR of 1.8%. There are several factors which are prohibiting the growth of the market such as extremely high cost of cancer treatment and drugs, lack of early diagnosis, lack of awareness and healthcare facilities particularly in African countries etc. Market Players: F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (US), Novartis AG(Switzerland), Abbott (US), Beckman Coulter Inc. (US), Debiopharm Group (Switzerland), AbbVie Inc. (US), Bayer AG (Germany) Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/2551 Regional Analysis: Considering the Middle-East and Africa Colorectal Cancer Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Colorectal Cancer. Moreover Saudi Arabia market is also growing and second largest market for Patient monitoring devices. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Colorectal Cancer during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market. Access the market data and market information presented through more than 25 market data tables and 25 figures spread over 80 numbers of pages of the project report “Middle-East and Africa Colorectal Cancer Market- Forecast to 2022” Market Segmentation: Middle-East and Africa Colorectal Cancer market has been segmented on the basis of type which Adenocarcinomas, Carcinoid tumors, Gastrointestinal stromal tumors (GISTs), Lymphomas, Sarcomas, and others. On the basis of diagnosis the market is segmented into Faecal Occult Blood Test, Colonoscopy, Virtual Colonoscopy, Stool DNA test, Digital Rectal Examination, Flexible Sigmoidoscopy, Biopsy, Magnetic resonance imaging (MRI), and Others. On the basis of treatment type market is segmented into Surgery, Radiation Therapy, Chemotherapy, targeted drug therapy, and others. Access Report Details @ https://www.marketresearchfuture.com/reports/mea-colorectal-cancer-market-2551 Intended Audience • Middle-East and Africa Colorectal Cancer Equipment manufacturers • Middle-East and Africa Colorectal Cancer Equipment Suppliers • Government and Independent Regulatory Authorities • Research and Development (R&D) Companies • Independent Research Laboratories • Market Research and Consulting Service Providers • Medical Research Laboratories About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact Info:Name: Akash AnandEmail: akash.anand@marketresearchfuture.comOrganization: Market Research FutureAddress: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, IndiaPhone: +1 646 845 9312Source URL: http://marketersmedia.com/colorectal-cancer-market-is-estimated-to-grow-at-a-cagr-over-1-8-by-2022/189547For more information, please visit https://www.marketresearchfuture.comSource: MarketersMediaRelease ID: 189547

Loading Independent Research collaborators
Loading Independent Research collaborators